ASC4OPT: A Phase 3b Open-Label Optimization Study of Oral Asciminib in Chronic Myelogenous Leukemia in Chronic Phase Previously Treated with 2 or More Tyrosine Kinase Inhibitors / Breccia, Massimo; Turkina, Anna; Boquimpani, Carla; Chuah, Charles; Sharf, Giora; Di Caprio, Luigi; Hoch, Matthias; Yssel, Justin; Zhang, Yifan; Hochhaus, Andreas. - In: BLOOD. - ISSN 0006-4971. - 140:1(2022), pp. 9635-9636. [10.1182/blood-2022-157991]
ASC4OPT: A Phase 3b Open-Label Optimization Study of Oral Asciminib in Chronic Myelogenous Leukemia in Chronic Phase Previously Treated with 2 or More Tyrosine Kinase Inhibitors
Breccia, Massimo;
2022
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
